Filtered By:
Source: Nutrition, Metabolism and Cardiovascular Diseases
Therapy: Dialysis

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 3 results found since Jan 2013.

The Risks of Stroke and Bleeding for Warfarin Use in Hemodialysis Patients with Atrial Fibrillation: A Systemic Review and A Meta-Analysis
Conclusion This meta-analysis suggested that warfarin should not be recommended for the routine treatment of HD patients with AF.
Source: Nutrition, Metabolism and Cardiovascular Diseases - April 3, 2015 Category: Nutrition Source Type: research

Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis
Conclusion This meta-analysis suggested that warfarin should not be recommended for the routine treatment of HD patients with AF.
Source: Nutrition, Metabolism and Cardiovascular Diseases - July 20, 2015 Category: Nutrition Source Type: research

The “Sapienza University Mortality and Morbidity Event Rate (SUMMER) Study in Diabetes”: Study Protocol
Discussion The “SUMMER study in diabetes” is aimed at identifying new molecular promoters of mortality and major vascular events in patients with T2DM. Most likely, these novel pathogenic factors will be instrumental for unraveling new pathways underlying such dramatic events. In addition, they will also be used as additional markers to increase the performance of already existing risk-scoring models in predicting the above mentioned outcomes in T2DM, as well as in setting up new preventive and treatment strategies, possibly tailored to specific pathogenic backgrounds.
Source: Nutrition, Metabolism and Cardiovascular Diseases - October 9, 2015 Category: Nutrition Source Type: research